Reduction-mediated technetium-99m labeling of monoclonal antibodies

J Nucl Med. 1990 May;31(5):692-7.

Abstract

A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with 99mTc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater than 97%), in a final labeling step taking only a few minutes, can be routinely obtained with high in-vitro stability over 24 hr. No effect upon antibody reactivity is seen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal* / pharmacokinetics
  • Isotope Labeling / methods*
  • Mice
  • Technetium*
  • Tissue Distribution

Substances

  • Antibodies, Monoclonal
  • Technetium